GE Healthcare:企業の戦略・SWOT・財務分析

◆英語タイトル:GE Healthcare - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY4535
◆発行会社(調査会社):MarketLine
◆発行日:2020年2月
◆ページ数:59
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥18,200見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥36,400見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥54,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

GE Healthcare – Strategy, SWOT and Corporate Finance Report
Summary

GE Healthcare – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

GE Healthcare (or ‘the company’), a business segment of General Electric (GE), is one of the leading providers of medical technologies and related services. The company offers medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement, and performance solutions services. It also distributes products and services for biopharmaceutical manufacturing, diagnostic imaging and clinical systems; cellular technologies; drug discovery, imaging agents; and arange of healthcare IT solutions. It operates in more than hundred countries through subsidiaries and affiliates. The company is headquartered in Buckinghamshire, the UK.

Scope

- Detailed information on GE Healthcare required for business and competitor intelligence needs
- A study of the major internal and external factors affecting GE Healthcare in the form of a SWOT analysis
- An in-depth view of the business model of GE Healthcare including a breakdown and examination of key business segments
- Intelligence on GE Healthcare’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about GE Healthcare, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of GE Healthcare and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess GE Healthcare as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on GE Healthcare’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
GE Healthcare: Company Overview
GE Healthcare: Overview and Key Facts
GE Healthcare: Overview
GE Healthcare: Key Facts
GE Healthcare: Key Employees
GE Healthcare: Key Employee Biographies
GE Healthcare: Major Products and Services
GE Healthcare: Company History
GE Healthcare: Management Statement
GE Healthcare: Locations and Subsidiaries
GE Healthcare: Key Competitors
GE Healthcare: Company Analysis
GE Healthcare: Business Description
GE Healthcare: SWOT Analysis
GE Healthcare: SWOT Overview
GE Healthcare: Strengths
GE Healthcare: Weaknesses
GE Healthcare: Opportunities
GE Healthcare: Threats
GE Healthcare: Corporate Financial Deals Activity
GE Healthcare: Financial Deals Overview
GE Healthcare: Targets and Partners
GE Healthcare: Top Deals 2016 – 2020YTD*
GE Healthcare: Advisors
GE Healthcare: Top Legal Advisors
GE Healthcare: Top Financial Advisors
GE Healthcare: Mergers and Acquisitions
GE Healthcare: Corporate Venturing
GE Healthcare: Partnership
GE Healthcare: Divestments
GE Healthcare: Recent Developments
GE Healthcare: News and Events Summary
GE Healthcare: Business Expansion
GE Healthcare: Contracts
GE Healthcare: Market Developments
GE Healthcare: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: GE Healthcare: Key Facts
Table 2: GE Healthcare: Key Employees
Table 3: GE Healthcare: Company History
Table 4: GE Healthcare: Locations and Subsidiaries
Table 5: GE Healthcare: Key Competitors
Table 6: GE Healthcare: Deal Activity by Deal Type - Volume (TTM*)
Table 7: GE Healthcare: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 8: GE Healthcare: Targets and Partners
Table 9: GE Healthcare: Top Deals 2016 - 2020YTD*
Table 10: GE Healthcare: Legal Advisor Ranking by Value (US$m)
Table 11: GE Healthcare: Financial Advisor Ranking by Value (US$m)
Table 12: GE Healthcare: M&A Volume and Value Trend (2016 - YTD*2020)
Table 13: GE Healthcare: M&A Activity by Geography (2016 - YTD*2020)
Table 14: GE Healthcare: Corporate Venturing Volume and Value Trend (2016 - YTD*2020)
Table 15: GE Healthcare: Corporate Venturing by Geography (2016 - YTD*2020)
Table 16: GE Healthcare: Partnership Volume and Value Trend (2016 - YTD*2020)
Table 17: GE Healthcare: Partnership Trend by Deal Type (2016 - YTD*2020)
Table 18: GE Healthcare: Divestments Volume and Value Trend (2016 - YTD*2020)
Table 19: GE Healthcare: Divestments by Geography (2016 - YTD*2020)
Table 20: GE Healthcare: News and Events Summary
Table 21: GE Healthcare: Business Expansion
Table 22: GE Healthcare: Contracts
Table 23: GE Healthcare: Market Developments
Table 24: GE Healthcare: Strategy and Operations

★海外企業調査レポート[GE Healthcare:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Reata Pharmaceuticals Inc (RETA):企業の財務・戦略的SWOT分析
    Summary Reata Pharmaceuticals Inc (Reata) is a clinical-stage biopharmaceutical company that develops innovative medicines for the treatment of serious and life-threatening diseases. The company’s clinical candidates include bardoxolone methyl and omaveloxolone, which target Nrf2, a transcription fa …
  • Torii Pharmaceutical Co Ltd (4551)-製薬・医療分野:企業M&A・提携分析
    Summary Torii Pharmaceutical Co Ltd (Torii) a subsidiary of Japan Tobacco Inc is a healthcare product provider that manufactures and markets products such as antebate ointment, antebate cream and urinorm used for the treatment of hyperuricemia and gout. The company offers products for the treatment …
  • Biotronik SE & Co KG:企業の戦略的SWOT分析
    Biotronik SE & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Impax Laboratories Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Impax Laboratories Inc (Impax) develops, manufactures and markets generic and branded pharmaceuticals. It offers solid dose and alternative dosage form generic drugs in a broad range of therapeutic areas; and proprietary branded pharmaceutical products for the treatment of central nervous sy …
  • Venus Remedies Ltd (VENUSREM)-製薬・医療分野:企業M&A・提携分析
    Summary Venus Remedies Ltd (Venus) is a pharmaceutical company that develops, manufactures and commercializes research, herbal and generic products. The company manufactures complex formulations for oncology injections, neurology, antiseptic, pain management, anti infectives, oncology lyophilized, l …
  • Varta AG (VAR1):企業の財務・戦略的SWOT分析
    Varta AG (VAR1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • GMR Infrastructure Limited (GMRINFRA)-エネルギー分野:企業M&A・提携分析
    Summary GMR Infrastructure Limited (GMR), a subsidiary of GMR Enterprises Private Limited, is a holding company which undertakes various projects across airport, energy, transportation and urban infrastructure sectors. The company owns and operates Delhi's Indira Gandhi International Airport, Rajiv …
  • Severn Trent Plc:企業の戦略・SWOT・財務分析
    Severn Trent Plc - Strategy, SWOT and Corporate Finance Report Summary Severn Trent Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Omnicell Inc (OMCL):企業の財務・戦略的SWOT分析
    Omnicell Inc (OMCL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Mississippi Power Co:企業の戦略的SWOT分析
    Mississippi Power Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Omron Healthcare Co Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Omron Healthcare Co Ltd (Omron Healthcare), a subsidiary of Omron Corp, is a provider of medical equipment for health monitoring and therapy. The company offers blood pressure monitors, digital thermometers, body fat meters, pedometers, nebulizers, body composition monitors and electric toot …
  • Etex Group Sa:企業の戦略・SWOT・財務分析
    Etex Group Sa - Strategy, SWOT and Corporate Finance Report Summary Etex Group Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Ageas NV:企業の戦略・SWOT・財務情報
    Ageas NV - Strategy, SWOT and Corporate Finance Report Summary Ageas NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • LegoChem Biosciences Inc (141080):製薬・医療:M&Aディール及び事業提携情報
    Summary LegoChem Biosciences Inc (LCB) is a biopharmaceutical company that develops next generation novel therapeutics. The company utilizes its proprietary medicinal drug discovery technology LegoChemistry and ADC platform technology ConjuAll. It manufactures drugs in the therapeutic areas of antib …
  • Sumitomo Heavy Industries Construction Cranes Co., Ltd.
    Sumitomo Heavy Industries Construction Cranes Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Heavy Industries Construction Cranes Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the compan …
  • BlueWillow Biologics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary BlueWillow Biologics Inc (BlueWillow), formerly NanoBio Corp is a biopharmaceutical company that develops intranasal and intramuscular vaccines for the prevention and treatment of infectious diseases. The company’s pipeline products include anthrax, H5 influenza, pertussis, RSV, HSV-2, and s …
  • Saipem SpA (SPM):石油・ガス:M&Aディール及び事業提携情報
    Summary Saipem SpA (Saipem) is an engineering, procurement, construction (EPC) contractor. It provides integrated basic design, Pre-front end engineering design (FEED), FEED and detailed EPC and project management services for complex offshore and onshore projects in the oil and gas industry. The co …
  • Granules India Ltd (GRANULES):製薬・医療:M&Aディール及び事業提携情報
    Summary Granules India Ltd (Granules) is a pharmaceutical manufacturing company, which carries out the research, development and manufacture of active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs) and finished dosages (FDs). The company manufactures Paracetomol, …
  • Fortive Corporation:戦略・SWOT・企業財務分析
    Fortive Corporation - Strategy, SWOT and Corporate Finance Report Summary Fortive Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Hexza Corp Bhd (HEXZA):企業の財務・戦略的SWOT分析
    Hexza Corp Bhd (HEXZA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆